Literature DB >> 26299432

Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs.

Peter Jorth1, Benjamin J Staudinger2, Xia Wu3, Katherine B Hisert2, Hillary Hayden1, Jayanthi Garudathri1, Christopher L Harding1, Matthew C Radey1, Amir Rezayat1, Gilbert Bautista1, William R Berrington2, Amanda F Goddard1, Chunxiang Zheng3, Angus Angermeyer1, Mitchell J Brittnacher1, Jacob Kitzman3, Jay Shendure3, Corinne L Fligner4, John Mittler1, Moira L Aitken2, Colin Manoil3, James E Bruce3, Timothy L Yahr5, Pradeep K Singh6.   

Abstract

Bacterial lineages that chronically infect cystic fibrosis (CF) patients genetically diversify during infection. However, the mechanisms driving diversification are unknown. By dissecting ten CF lung pairs and studying ∼12,000 regional isolates, we were able to investigate whether clonally related Pseudomonas aeruginosa inhabiting different lung regions evolve independently and differ functionally. Phylogenetic analysis of genome sequences showed that regional isolation of P. aeruginosa drives divergent evolution. We investigated the consequences of regional evolution by studying isolates from mildly and severely diseased lung regions and found evolved differences in bacterial nutritional requirements, host defense and antibiotic resistance, and virulence due to hyperactivity of the type 3 secretion system. These findings suggest that bacterial intermixing is limited in CF lungs and that regional selective pressures may markedly differ. The findings also may explain how specialized bacterial variants arise during infection and raise the possibility that pathogen diversification occurs in other chronic infections characterized by spatially heterogeneous conditions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26299432      PMCID: PMC4589543          DOI: 10.1016/j.chom.2015.07.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  45 in total

1.  Lobar alveolar gas concentrations; effect of body position.

Authors:  C J MARTIN; F CLINE; H MARSHALL
Journal:  J Clin Invest       Date:  1953-07       Impact factor: 14.808

2.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

3.  Drug concentration heterogeneity facilitates the evolution of drug resistance.

Authors:  T B Kepler; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

4.  Adaptive radiation in a heterogeneous environment.

Authors:  P B Rainey; M Travisano
Journal:  Nature       Date:  1998-07-02       Impact factor: 49.962

5.  Distribution of disease in cystic fibrosis: correlation with pulmonary function.

Authors:  J W Gurney; T G Habbe; J Hicklin
Journal:  Chest       Date:  1997-08       Impact factor: 9.410

6.  Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; J Foster; J S Lam; D P Speert
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

7.  Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections.

Authors:  David Williams; Benjamin Evans; Sam Haldenby; Martin J Walshaw; Michael A Brockhurst; Craig Winstanley; Steve Paterson
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

Review 8.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

9.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.

Authors:  M J Struelens; V Schwam; A Deplano; D Baran
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Evidence for limited genetic compartmentalization of HIV-1 between lung and blood.

Authors:  Laura Heath; Alan Fox; Jan McClure; Kurt Diem; Angélique B van 't Wout; Hong Zhao; David R Park; Jeffrey T Schouten; Homer L Twigg; Lawrence Corey; James I Mullins; John E Mittler
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more
  139 in total

1.  Bacterial evolution: To divide and conquer.

Authors:  Denise Waldron
Journal:  Nat Rev Microbiol       Date:  2015-10       Impact factor: 60.633

2.  Facultative control of matrix production optimizes competitive fitness in Pseudomonas aeruginosa PA14 biofilm models.

Authors:  Jonas S Madsen; Yu-Cheng Lin; Georgia R Squyres; Alexa Price-Whelan; Ana de Santiago Torio; Angela Song; William C Cornell; Søren J Sørensen; Joao B Xavier; Lars E P Dietrich
Journal:  Appl Environ Microbiol       Date:  2015-10-02       Impact factor: 4.792

3.  It's diversity all the way down.

Authors:  Sophia David; James Hadfield
Journal:  Nat Rev Microbiol       Date:  2015-11-09       Impact factor: 60.633

4.  A Structure-Function-Inhibition Analysis of the Pseudomonas aeruginosa Type III Secretion Needle Protein PscF.

Authors:  Donald T Moir; Nicholas O Bowlin; Bryan J Berube; Jaden Yabut; Debra M Mills; Giang T Nguyen; Zachary D Aron; John D Williams; Joan Mecsas; Alan R Hauser; Terry L Bowlin
Journal:  J Bacteriol       Date:  2020-08-25       Impact factor: 3.490

Review 5.  Pseudomonas aeruginosa polymicrobial interactions during lung infection.

Authors:  Karishma Bisht; Jiwasmika Baishya; Catherine A Wakeman
Journal:  Curr Opin Microbiol       Date:  2020-02-12       Impact factor: 7.934

6.  Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions.

Authors:  Alana Schick; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

7.  Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa.

Authors:  Patrick R Secor; Lia A Michaels; Anina Ratjen; Laura K Jennings; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

8.  Pseudomonas aeruginosa-Derived Rhamnolipids and Other Detergents Modulate Colony Morphotype and Motility in the Burkholderia cepacia Complex.

Authors:  Steve P Bernier; Courtney Hum; Xiang Li; George A O'Toole; Nathan A Magarvey; Michael G Surette
Journal:  J Bacteriol       Date:  2017-06-13       Impact factor: 3.490

9.  Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.

Authors:  Muhammad-Hariri Mustafa; Hussein Chalhoub; Olivier Denis; Ariane Deplano; Anne Vergison; Hector Rodriguez-Villalobos; Michael M Tunney; J Stuart Elborn; Barbara C Kahl; Hamidou Traore; Francis Vanderbist; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 10.  Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.

Authors:  Elio Rossi; Ruggero La Rosa; Jennifer A Bartell; Rasmus L Marvig; Janus A J Haagensen; Lea M Sommer; Søren Molin; Helle Krogh Johansen
Journal:  Nat Rev Microbiol       Date:  2020-11-19       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.